Dr. Pittman's primary research interest is improving the diagnosis and detection of early lung disease in infancy and early childhood through the use of novel outcome measures including infant pulmonary function testing and multiple breath washout (MBW) testing. She is a past recipient of the Cystic Fibrosis Foundation Leroy Matthews Physician/Scientist Award (2010 - 2013) and recently received an NIH K12 award through the Washington University School of Medicine Omics of Inflammatory Airways Disease K12 Program. She has served as the Associate Director of the Cystic Fibrosis Foundation Therapeutics Development Network Center for Infant and Preschool Pulmonary Function Testing since 2011; her lab focuses on improving the standardization of multiple breath washout testing and collecting normative data for MBW measures. Dr. Pittman has participated in research studies involving children with cystic fibrosis, primary ciliary dyskinesia, and asthma/wheeze, including several multi-center NIH studies. Her most recent research projects aim to improve our understanding of the pathophysiology of early childhood lung disease (particularly cystic fibrosis) by investigating the association of functional/physiologic measures (multiple breath washout testing, infant pulmonary function testing), imaging studies (ventilation studies using MRI), and more basic measures of disease such as the respiratory microbiome and pulmonary inflammatory markers.